Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:10 PM
Ignite Modification Date:
2025-12-24 @ 10:10 PM
NCT ID:
NCT02460835
Eligibility Criteria:
Inclusion Criteria:
* Patients must have hepatocellular carcinoma.
* Patients must not have extrahepatic cancer.
* Patients must not be eligible for a curative liver resection or have refused resection
* Patients must have recovered from the acute effects of prior liver-directed therapy and 4 weeks must have passed since the last procedure and protocol therapy.
* Patients must have a Zubrod performance status of less than or equal to 2 (Zubrod performance status is a measure that attempts to quantify a cancer patients' general well-being. Scores run from 0 to 5 where 0 denotes normal activity and 5 denotes death).
* Patients must be 18 years of age or older.
* Patients must have adequate organ function.
* Patients must understand and be willing to sign an IRB (Institutional Review Board) approved informed consent form.
Exclusion Criteria:
* Patients with known allergies to intravenous iodinated contrast agents.
* Patients with a contraindication to contrast-enhanced MRI are excluded.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02460835
Study Brief:
Protocol Section:
NCT02460835